{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:51:39Z","timestamp":1791103899701,"version":"4.1.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1996,1,1]],"date-time":"1996-01-01T00:00:00Z","timestamp":820454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[1996,1]]},"DOI":"10.1136\/ard.55.1.66","type":"journal-article","created":{"date-parts":[[2008,7,28]],"date-time":"2008-07-28T23:49:46Z","timestamp":1217288986000},"page":"66-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis."],"prefix":"10.1016","volume":"55","author":[{"given":"C","family":"Beyeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.A","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R","family":"Idle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.K","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0165-6147(92)90107-H","article-title":"Human cytochromes P450: problems and prospects","volume":"13","author":"J, Gonzalez F.","year":"1992","unstructured":"Gonzalez F J. Human cytochromes P450: problems and prospects. Trends Pharmacol Sci 1992; 13: 346-52.","journal-title":"Trends Pharmacol Sci"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0165-6147(92)90140-2","article-title":"The role of individual human cytochromes P450 in drug metabolism and clinical response","volume":"13","author":"Cholerton, S.; K, Daly A.; R, Idle J.","year":"1992","unstructured":"Cholerton S, Daly A K, Idle J R. The role of individual human cytochromes P450 in drug metabolism and clinical response. Trends Pharmacol Sci 1992; 13: 434-8.","journal-title":"Trends Pharmacol Sci"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00008571-199110000-00006","article-title":"Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes","volume":"1","author":"K, Daly A.; M, Armstrong; C, Monkman S.; E, Idle M.; R, Idle J.","year":"1991","unstructured":"Daly A K, Armstrong M, Monkman S C, Idle M E, Idle J R. Genetic and metabolic criteria for the assignment of debrisoquine 4-hydroxylation (cytochrome P4502D6) phenotypes. Pharmacogenetics 1991; 1: 33-41.","journal-title":"Pharmacogenetics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1289\/ehp.94102s955","article-title":"Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility","volume":"102","author":"K, Daly A.; S, Cholerton; M, Armstrong; R, Idle J.","year":"1994","unstructured":"Daly A K, Cholerton S, Armstrong M, Idle J R. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility. Environ Health Perspect 1994; 102: 55-61.","journal-title":"Environ Health Perspect"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/art.1780290705","article-title":"Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus","volume":"29","author":"N, Baer A.; B, McAllister C.; R, Wkllinson G.; L, Woosley R.; T, Pincus","year":"1986","unstructured":"Baer A N, McAllister C B, Wkllinson G R, Woosley R L, Pincus T. Altered distribution of debrisoquine oxidation phenotypes in patients with systemic lupus erythematosus. Arthritis Rheum 1986; 29: 843-9.","journal-title":"Arthritis Rheum"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/clpt.1990.151","article-title":"Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin and mephenytoin","volume":"48","author":"G, May D.","year":"1990","unstructured":"May D G, Black C M, Olsen N J, et al. Scleroderma is associated with differences in individual routes of drug metabolism: a study with dapsone, debrisoquin and mephenytoin. Clin Pharmacol Ther 1990; 48: 286-95.","journal-title":"Clin Pharmacol Ther"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0889-857X(21)00154-X","article-title":"Immunogenetics of spondyloarthropathies","volume":"18","author":"A, Khan M.; H, Kellner","year":"1992","unstructured":"Khan M A, Kellner H. Immunogenetics of spondyloarthropathies. Rheum Dis Clin North Am 1992; 18: 837-64.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0889-857X(21)00151-4","article-title":"Prediction of susceptibility to rheumatoid arthritis by human leukozyte antigen genotyping","volume":"18","author":"T, Nepom G.; S, Nepom B.","year":"1992","unstructured":"Nepom G T, Nepom B S. Prediction of susceptibility to rheumatoid arthritis by human leukozyte antigen genotyping. Rheum Dis Clin North Am 1992; 18: 785-92.","journal-title":"Rheum Dis Clin North Am"},{"key":"ref_9","first-page":"315","article-title":"revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"C, Arnett F.; M, Edworthy S.; H, Block D.","year":"1987","unstructured":"Arnett F C, Edworthy S M, Block D H, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.","journal-title":"The American Rheumatism Association"},{"key":"ref_10","article-title":"Statistics with Confidence","author":"J, Gardner M.; G, Altman D.","year":"1989","unstructured":"Gardner M J, Altman D G. Statistics with Confidence. London: BMJ, 1989."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/carcin\/13.6.1035","article-title":"Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility","volume":"13","author":"R, Wolf C.; D, Smith C.A.; C, Gough A.","year":"1992","unstructured":"Wolf C R, Smith C A D, Gough A C, et al. Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 1992; 13: 1035-8.","journal-title":"Carcinogenesis"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/0140-6736(92)91196-F","article-title":"Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease","volume":"339","author":"D, Smith C.A.; C, Gough A.; N, Leigh P.","year":"1992","unstructured":"Smith C A D, Gough A C, Leigh P N, et al. Debrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease. Lancet 1992; 339: 1375-7.","journal-title":"Lancet"},{"key":"ref_13","first-page":"1034","article-title":"Phenotype\/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: Influence of drug therapy and disease activity","volume":"21","author":"Beyeler, C.; K, Daly A.; Armstrong, M.; Astbury, C.; A, Bird H.; R, Idle J.","year":"1994","unstructured":"Beyeler C, Daly A K, Armstrong M, Astbury C, Bird H A, Idle J R. Phenotype\/genotype relationships for the cytochrome P450 enzyme CYP2D6 in rheumatoid arthritis: Influence of drug therapy and disease activity. J Rheumatol 1994; 21: 1034-9.","journal-title":"J Rheumatol"},{"key":"ref_14","first-page":"686","article-title":"Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine","volume":"49","author":"H, Sindrup S.","year":"1991","unstructured":"Sindrup S H, Brosen K, Bjerring K, et al. Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin Pharmacol Ther 1991; 49: 686-93.","journal-title":"Clin Pharmacol Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724029534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724029534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.55.1.66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T08:43:28Z","timestamp":1737449008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724029534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1996,1]]}},"alternative-id":["S0003496724029534"],"URL":"https:\/\/doi.org\/10.1136\/ard.55.1.66","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[1996,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between genotype for the cytochrome P450 CYP2D6 and susceptibility to ankylosing spondylitis and rheumatoid arthritis.","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.55.1.66","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1996 \u00a9 THE AUTHORS. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology, EULAR. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}